Abstract
Purpose
Graves’ disease (GD) is an autoimmune disorder affecting primarily the thyroid gland. The most common extrathyroidal manifestation of GD is known as Graves’ orbitopathy (GO). Bone marrow-derived fibrocytes represent a subset of monocytes in peripheral blood mononuclear cells (PBMCs), infiltrate the orbital tissues, and contribute to the pathogenesis of GO. Hence objectives of the study included whether the concentration of fibrocytes in peripheral blood was higher in GO, whether TSHR m RNA expression and TSHR surface expression in peripheral blood were higher in GO in comparison to Graves’ Disease (GD) and Control subjects.
Methods
The percentage of circulating fibrocytes (FC) along with TSHR on its cell surface (CD 34+, CD 45+, CXCR4+, Collagen 1+, TSHR+) were assessed by flow cytometry of 50 patients with GD and GO and 15 healthy donors (Control). TSHR mRNA expression was measured by q RT PCR.
Result
The concentration of circulating fibrocytes was significantly higher in GO compared to GD and control [GO 17% vs GD 3% vs control 0.7% (p < 0.05)]. Moreover, these fibrocytes express a significantly higher level of TSHR in GO. This was corroborated by the measure of TSH mRNA; in GD it was 2.3-fold higher and in GO it was 3.9 fold higher than in control, in GO this transcript level was 1.7fold higher than GD (p < 0.05). TSHR+ fibrocytes were significantly positively correlated with CAS (p = 0.004) and negatively correlated with age (p = 0.01) and duration of disease (p = 0.01) in GO.
Conclusion
This study sheds further light on the pathogenesis of GO.
Similar content being viewed by others
Data availability
The datasets used and analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- GO:
-
Graves’ Orbitopathy
- TSHR:
-
Thyroid Stimulating Hormone Receptor
- GD:
-
Graves’ Disease
- PBMC:
-
Peripheral Blood mononuclear cells
- FC:
-
Fibrocytes
- CAS:
-
Clinical Activity Score
- mRNA:
-
Messenger Ribonucleic Acid
- EUGOGO:
-
European Group of Graves’ Orbitopathy
- MRI:
-
Magnetic resonance imaging
- CLIA:
-
Chemiluminescence Immune Assay
- ECLIA:
-
Electrochemiluminescence Immune Assay
- TRAb:
-
Thyroid Stimulating Hormone Receptor Antibody
- qRT-PCR:
-
quantitative Real Time Polymerase Chain Reaction
- GAPDH:
-
glyceraldehyde-3-phosphate dehydrogenase
- CI:
-
Confidence Interval.
References
E. Macchia, G.F. Fenzi, F. Monzani, L. Bartalena, F. Lippi, V. Aloisio, C. Cupini, L. Baschieri, A. Pinchera, TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves’ disease. J. Endocrinol. Invest 6, 375–378 (1983). https://doi.org/10.1007/BF03347619
R.S. Douglas, N.F. Afifiyan, C.J. Hwang, K. Chong, U. Haider, P. Richards, A.G. Gianoukakis, T.J. Smith, Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 95(1), 430–438 (2010). https://doi.org/10.1210/jc.2009-1614. January
T.J. Smith, A. Dolly, P. Claudio, L.U. Ying, N. Raychaudhuri, R. Fernando, S. Atkins, F. Erin, A.G.G. Gianoukakis, B.S. Miller, P.G. Gauger, G.M. Doherty, R.S. Douglas, Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves’ disease. J. Clin. Endocrinol. Metab. 96(12), 3827–3837 (2011). https://doi.org/10.1210/jc.2011-1249.
Y.S. Hussain, J.C. Hookham, A. Allahabadia, S.P. Balasubramanian, Epidemiology, management and outcomes of Graves’ disease—real lifedata. Endocrine 56, 568–578 (2017). https://doi.org/10.1007/s12020-017-1306-5
P.M. Sudeep, P. Petros, Epidemiology of Graves’ orbitopathy. Pediatr. Endocrinol. Rev. 7(Suppl 2), 182–185 (2010). PMID: 20467360
M. Basak, N. Agrawal, S. Mondal, S. Chowdhury, S. Guria, A clinicopathogenetic study on graves’ orbitopathy in a tertiary care hospital setting in eastern India. ijcmpr ume-6(Issue 01), No.4876–4881 (2020). https://doi.org/10.24327/23956429.ijcmpr202001823. JanuaryAPage
P. Heukels, J.A.C. van Hulst, M. van Nimwegen, C.E. Boorsma, B.N. Melgert, K.L.M. van den Toorn, A.T. Boomars, M.S. Wijsenbeek, H. Hoogsteden, J.H. von der Thüsen, R.W. Hendriks, M. Kool, B. Blink van den, Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis. Respiratory Res. 19, 90 (2018). https://doi.org/10.1186/s12931-018-07988
P. Darrell, H.G. Richard, Differentiation of circulating monocytes into fibroblast-like cells methods. Mol. Biol. 904, 191–206 (2012). https://doi.org/10.1007/978-1-61779-943-3_16
C.L. Galligan, E.N. Fish, The role of circulating fibrocytes in inflammation and autoimmunity. J. Leukoc. Biol. ume 93(1), 45–50 (January 2013). https://doi.org/10.1189/jlb.0712365
E.F. Gillespie, K.I. Papageorgiou, R. Fernando, N. Raychaudhuri, K.P. Cockerham, L.K. Charara, A.C.P. Goncalves, S.X. Zhao, A. Ginter, Y. Lu, T.J. Smith, R.S. Douglas, Increased Expression of TSH Receptor by Fibrocytes in Thyroid-Associated Ophthalmopathy Leads to Chemokine Production. J. Clin. Endocrinol. Metab. 97, E740–E746 (2012). https://doi.org/10.1210/jc.2011-2514
S. Iyer, R. Bahn, Immunopathogenesis of Graves’ ophthalmopathy: the role of the TSH receptor. Best. Pr. Res Clin. Endocrinol. Metab. 26(3), 281–289 (June 2012). https://doi.org/10.1016/j.beem.2011.10.003
J. Barrio-Barrio, A.L. Sabater, E. Bonet-Farriol, Á. Velázquez-Villoria, J.C. Galofré. Graves’ ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. Journal of ophthalmology (2015). https://doi.org/10.1155/2015/249125
A. Moeller, S.E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, J.M. Peter, L. Farkas, J. Dobranowski, C. Boylan, P.M. O’Byrne, R.M. Strieter, M. Kolb, Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med 179, 588–594 (2009). https://doi.org/10.1164/rccm.200810-1534oc. pp
T. Sanyal, P. Bhattacharjee, S. Bhattacharjee, Hypomethylation of mitochondrial D-loop and ND6 with increased mitochondrial DNA copy number in the arsenic-exposed population. Toxicology 408, 54–61 (Sep 2018). https://doi.org/10.1016/j.tox.2018.06.012
P. Chinnappa, L. Taguba, R. Arciaga, C. Faiman, A. Siperstein, A.E. Mehta, S.K. Reddy, C. Nasr, M.K. Gupta, Detection of thyrotropin-receptor messenger ribonucleic acid (mrna) and thyroglobulin mrna transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer. J. Clin. Endocrinol. Metab. 89(8), 3705–3709 (August 2004). https://doi.org/10.1210/jc.2003-031967
Acknowledgements
We are grateful to all the study participants and the members of our research team for their kind support and cooperation. We are thankful to Prof Mitali Chatterjee [Nodal Officer, Multi-Disciplinary Research Unit (MRU) IPGME&R] for her guidance in flowcytometry.
Author contribution
M.B.: Conceptualization, Investigation, Visualization, writing original draft, T.S.: Analysis of RT PCR data, A.K.: Clinical data acquisition from patients, P.B.: Data curation, validation, writing- review and editing, M.D.: Initial Conceptualization, Project Administration, S.C.: Conceptualization, project administration, supervision, data curation, validation, writing- review and editing.
Funding
We are also thankful to Department of Higher Education, Science Technology and Biotechnology (DHESTBT, West Bengal, Sanction No. 298 (Sanc.)/ST/P/S&T/9G-24/2016 dated on 28.03.2018) and Endocrine Society of India (Sanction No. R2017002 dated on 26.08.2017) for their financial support in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
The study has the approval of institutional ethics committee [Institute of Post Graduate Medical Education and Research and SSKM Hospital, Kolkata, West Bengal, India. (Memo No. Inst/IEC/2016/445)].
Informed consent
Patients gave their informed written consent to participate.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Basak, M., Sanyal, T., Kar, A. et al. Peripheral blood mononuclear cells - Can they provide a clue to the pathogenesis of Graves’ Orbitopathy?. Endocrine 75, 447–455 (2022). https://doi.org/10.1007/s12020-021-02865-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-021-02865-0